Panning phage antibody libraries on cells: isolation of human Fab fragments against ovarian carcinoma using guided selection

M Figini, L Obici, D Mezzanzanica, A Griffiths… - Cancer research, 1998 - AACR
The display of repertoires of human antibody (Ab) fragments on filamentous phages and
selection by binding of the phage to antigen (Ag) have provided a ready means of deriving …

[HTML][HTML] Targeting folate receptor alpha for cancer treatment

…, J Bloomfield, M Fittall, A Grigoriadis, M Figini… - Oncotarget, 2016 - ncbi.nlm.nih.gov
Promising targeted treatments and immunotherapy strategies in oncology and advancements
in our understanding of molecular pathways that underpin cancer development have …

CD27 costimulation augments the survival and antitumor activity of redirected human T cells in vivo

…, Q Ye, M Poussin, GM Harms, M Figini… - Blood, The Journal …, 2012 - ashpublications.org
The costimulatory effects of CD27 on T lymphocyte effector function and memory formation
has been confined to evaluations in mouse models, in vitro human cell culture systems, and …

In Vivo Persistence, Tumor Localization, and Antitumor Activity of CAR-Engineered T Cells Is Enhanced by Costimulatory Signaling through CD137 (4-1BB)

…, Q Ye, C Carpenito, M Poussin, LP Wang, C Ji, M Figini… - Cancer research, 2011 - AACR
Human T cells engineered to express a chimeric antigen receptor (CAR) specific for folate
receptor-α (FRα) have shown robust antitumor activity against epithelial cancers in vitro but …

[HTML][HTML] Effective adoptive immunotherapy of triple-negative breast cancer by folate receptor-alpha redirected CAR T cells is influenced by surface antigen expression …

DG Song, Q Ye, M Poussin, JA Chacon, M Figini… - Journal of hematology & …, 2016 - Springer
Background The poor prognosis and the limited efficacy of targeted therapy in patients with
triple-negative breast cancer (TNBC) have raised the need for alternative therapies. Recent …

Activation of the osteopontin/matrix metalloproteinase-9 pathway correlates with prostate cancer progression

…, G Malaponte, MC Mazzarino, M Figini… - Clinical Cancer …, 2008 - AACR
Purpose: Prostate cancer remains the second most frequent cause of tumor-related deaths in
the Western world. Additional markers for the identification of prostate cancer development …

[HTML][HTML] Folate receptors and transporters: biological role and diagnostic/therapeutic targets in cancer and other diseases

…, CP Leamon, GJ Peters, PS Low, LH Matherly, M Figini - 2019 - Springer
Folate receptors and transporters and one-carbon metabolism continue to be important
areas of study given their essential roles in an assortment of diseases and as targets for …

Redirected activity of human antitumor chimeric immune receptors is governed by antigen and receptor expression levels and affinity of interaction

F Turatti, M Figini, E Balladore, P Alberti… - Journal of …, 2007 - journals.lww.com
Novel Ab-based immunotherapeutic strategies have exploited T-cell receptor-like chimeric
immune receptors (CIR) expressed on the surface of transduced human peripheral blood …

[HTML][HTML] Folate receptor alpha in ovarian cancer tissue and patient serum is associated with disease burden and treatment outcomes

…, AM Black, S Lombardi, S Canevari, M Figini… - British Journal of …, 2023 - nature.com
Background Survival rates for ovarian cancer remain poor, and monitoring and prediction of
therapeutic response may benefit from additional markers. Ovarian cancers frequently …

[HTML][HTML] A fully human chimeric antigen receptor with potent activity against cancer cells but reduced risk for off-tumor toxicity

DG Song, Q Ye, M Poussin, L Liu, M Figini… - Oncotarget, 2015 - ncbi.nlm.nih.gov
Chimeric antigen receptors (CARs) can redirect T cells against antigen-expressing tumors in
an HLA-independent manner. To date, various CARs have been constructed using mouse …